OrbusNeich Medical Group Holdings Limited (6929.HK)

HKD 4.08

(-0.97%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 153.86 Million 136.82 Million 116.46 Million 88.47 Million 96.34 Million
Cost of Revenue 47.36 Million 44.36 Million 35.29 Million 30.45 Million 30.89 Million
Gross Profit 106.49 Million 92.45 Million 81.17 Million 58.02 Million 65.44 Million
Operating Expenses 66.55 Million 68.32 Million 60.82 Million 51.16 Million 57.46 Million
Selling, General and Administrative Expenses 54.84 Million 55.12 Million 50.05 Million 40.98 Million 49.48 Million
Research and Development Expenses 14.81 Million 14.11 Million 12.14 Million 12.57 Million 9.59 Million
Other Expenses -3.09 Million 9000.00 -14.93 Million -43 Thousand -
Cost and Expenses 113.92 Million 112.69 Million 96.11 Million 81.61 Million 88.35 Million
Operating Income 39.93 Million 21.07 Million 19.44 Million 8.69 Million 7.65 Million
Interest Expense 142 Thousand 1.46 Million 5.6 Million 1.4 Million 501 Thousand
Income Tax Expense 4.55 Million 3.3 Million 3.12 Million 184 Thousand 549 Thousand
Earnings before Tax 49.62 Million 21.79 Million -1.31 Million 7.25 Million 7.5 Million
Net Income 45.07 Million 18.49 Million -4.44 Million 7.07 Million 6.95 Million
Earnings Per Share Basic 0.05 0.03 -0.01 0.01 0.01
Earnings Per Share Diluted 0.05 0.03 -0.01 0.01 0.01
Weighted Average Shares Outstanding 833.15 Million 724.08 Million 576.91 Million 576.94 Million 579.83 Million
Weighted Average Shares Outstanding (Diluted) 832.96 Million 776.38 Million 576.9 Million 576.9 Million 576.9 Million
Gross Margin 0.69 0.68 0.70 0.66 0.68
EBIT Margin 0.35 0.21 0.07 0.13 0.10
Profit Margin 0.29 0.14 -0.04 0.08 0.07
EBITDA 53.96 Million 27.13 Million 8.3 Million 12.74 Million 10.03 Million
Earnings Before Tax Margin 0.26 0.15 0.17 0.10 0.08

Income Statement Charts